Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy Volunteers

NCT03133351 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2020-04-16

No results posted yet for this study

Summary

This study is intended to define the PCM normal laboratory range.

Conditions

  • Coagulation

Interventions

DEVICE

PCM

A fresh whole blood sample will be tested by PCM to determine the reference range.

Sponsors & Collaborators

  • Entegrion, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-04
Primary Completion
2020-12-30
Completion
2021-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03133351 on ClinicalTrials.gov